Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4151–4200 of 33040
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Michael Treisman has resigned from his role as Vice President of the Company, effective February 12, 2025.
Michael Treisman has resigned from his role as Vice President of the Company, effective February 12, 2025.
Michael A. Stein notified the Board that he does not intend to seek re-election as a director
Thomas F. Glavin notified the Board that he does not intend to seek re-election as a director
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Executive Chairman of Newmark, informed the Company that he has stepped down as Chairman of the Board and Executive Chairman of the Company, effective February 18, 2025, as a result of his confirmation by the United States Senate as the 41st Secretary of Commerce.
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Chief Executive Officer of BGC Group, Inc. (“BGC” or the “Company”), informed the Company that he has stepped down as Chairman of the Board and Chief Executive Officer of the Company, effective February 18, 2025
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Chief Executive Officer of BGC Group, Inc. (“BGC” or the “Company”), informed the Company that he has stepped down as Chairman of the Board and Chief Executive Officer of the Company, effective February 18, 2025
On February 14, 2025, in connection with the Company’s ongoing bankruptcy cases, the Board made the decision to terminate all Company employees, including all executive officers except for Winston Mar of CR3 Partners, the Company’s Chief Restructuring Officer.
On February 14, 2025, in connection with the Company’s ongoing bankruptcy cases, the Board made the decision to terminate all Company employees, including all executive officers except for Winston Mar of CR3 Partners, the Company’s Chief Restructuring Officer.
On February 14, 2025, James J. Bottiglieri notified Compass Diversified Holdings (NYSE: CODI) and the Board of Directors (the “Board”) of Compass Group Diversified Holdings LLC (the “Company” and, together with Compass Diversified Holdings, “CODI”) that he would not be standing for re-election as a director of the Company at CODI’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”) due to his retirement.
On February 13, 2025, Mr. Thomas J. Winkel, a member of the Board of Directors of Marten Transport, Ltd. (the “Company”), notified the Company that he will not seek reelection as a director of the Company at the Company’s upcoming 2025 Annual Meeting of Stockholders for personal reasons.
As of February 12, 2025, The Board of Directors of PNXP accepted the Resignation of Mr. Matthew Feinstein as Chief Executive Officer "CEO", President, Directors and Chairman of the Board.
terminated the employment of Sara Silverstein, the Company’s Chief Executive Officer, without cause, effective the same day.
Mr. Spiegel succeeds Odely Sakazi, who departed the Partnership on February 12, 2025.
On February 14, 2025, ProMIS Neurosciences Inc. (the “Company”) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14, 2025
On February 14, 2025, Mr. C. Christopher Gaut informed the Board of Directors (the “Board”) of Forum Energy Technologies, Inc. (“FET”) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at FET’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On February 13, 2025, the Company accepted the resignation of Yuyang Cui from her positions as Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director.
On February 14, 2025, the Company entered into a Severance Agreement (the "Severance Agreement") with its Chief Operating Officer, Jason T. Archer, who resigned for personal reasons.
On February 13, 2025, Ali Dasdan, Chief Technology Officer of ZoomInfo Technologies Inc. (the "Company"), informed the Company of his decision to depart to pursue a new opportunity.
Mr. Sarner resigned from his positions of Chief Financial Officer, Chief Compliance Officer and Secretary of the Company, effective immediately.
Bowen S. Diehl notified the Board that he was stepping down as the President and Chief Executive Officer of the Company and as a director of the Board.
On February 12, 2025, Kelly Services, Inc. (the “Company”) was notified by Donald R. Parfet that he intends to retire as a director effective as of the date of the Company’s 2025 annual shareholders meeting.
Larry O. Spencer communicated to the Board his decision not to stand for reelection at the Company's 2025 Annual Meeting of Stockholders.
On February 14, 2025, Ms. Robin L. Washington notified the Board of Directors (the “Board”) of Honeywell International Inc. (the “Company”) that she intends to resign from the Board, effective as of March 31, 2025.
On February 18, 2025, Brenda Lauderback, Chair of the Board of Directors (the "Board") of Denny's Corporation (the "Company"), notified the Company of her decision to retire from the Board effective May 14, 2025, at the conclusion of her existing term.
On February 14, 2025, Mr. Umesh Mahajan, Co-Chief Investment Officer, Chief Financial Officer and Secretary of the Company, resigned from his position as Chief Financial Officer of the Company.
On February 13, 2025, Curtis V. Anastasio notified the Board of Directors (the "Board") of The Chemours Company (the "Company") of his decision not to seek re-election to the Board at the Company's 2025 Annual Meeting of Stockholders, when his current term expires.
On February 13, 2025, each of Denise Brooks-Williams and Shekar Narasimhan informed Broadstone Net Lease, Inc. (referred to herein as the “Company,” “we,” “our,” or “us”) that they would not stand for re-election as directors of the Company and that the decision not to stand for re-election did not involve any disagreement with the Company.
On February 13, 2025, each of Denise Brooks-Williams and Shekar Narasimhan informed Broadstone Net Lease, Inc. (referred to herein as the “Company,” “we,” “our,” or “us”) that they would not stand for re-election as directors of the Company and that the decision not to stand for re-election did not involve any disagreement with the Company.
Ms. Giles will replace Robert Walsh, who will step down as Citi’s interim Chief Accounting Officer, effective as of February 21, 2025.
Kulesh Shanmugasundaram, Chief Technology Officer of the Company, informed the Company that he will resign from his role, effective as of March 31, 2025
On February 14 , 2025, Sandra Leung notified Bristol-Myers Squibb Company (the “Company”) of her intention to retire from her position as Executive Vice President, General Counsel in 2025.
Katrina Sparano retired as the Company’s Chief Financial Officer and Treasurer effective February 15, 2025.
On February 12, 2025, Gary K. Adams and Denise L. Ramos each informed the Board of Directors (the “Board”) of Phillips 66 (the “Company”) of their intent not to stand for reelection to the Board at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”).
On February 12, 2025, Gary K. Adams and Denise L. Ramos each informed the Board of Directors (the “Board”) of Phillips 66 (the “Company”) of their intent not to stand for reelection to the Board at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”).
Effective February 13, 2025, Milton H. Werner, Ph.D. resigned as President, Chief Executive Officer and principal executive officer of Inhibikase Therapeutics, Inc. (the “Company”) and as a member of the Board of Directors (the “Board”) of the Company (the “Resignation”).
Mr. LaRose became a full-time non-officer employee of the Company, and is expected to remain employed for a transition period ending on April 30, 2025.
Ms. Simmons resigned from the Board
On February 18, 2025, Norwood Financial Corp (the “Company”) announced that Susan Campfield retired from the Board of Directors of the Company and its wholly-owned subsidiary, Wayne Bank.
On February 12, 2025, Cidara Therapeutics, Inc. (the “Company”) and Preetam Shah, Ph.D., MBA., the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, mutually agreed to Dr. Shah’s separation from such roles with the Company, effective February 24, 2025
On February 12, 2025, John Mazzola notified the Company that he intends to retire from his position as Chief Operating Officer of Vicarious Surgical Inc. (the “Company”), effective April 1, 2025.
On February 18, 2025, Christian Brühlmann resigned from his position as Chief Strategy Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.